Follow up sales of FelixTM System
Filed with ASX · · 3 pages · English
The FelixTM System is a patented, rapid, automated device for quickly and gently separating high quality sperm from a semen sample for use in human IVF procedures. It is proven from comprehensive in vitro testing to be more effective than current procedures in selecting quality sperm from a wider range of semen samples, including most types of poor-quality samples. The Indian Women’s Center IVF cl
Earlier from Memphasys
- MEM Achieves ISO 13485 Compliance
- Appendix 4D and Half Year Report and Accounts
- First Felix System commercial sale for clinical IVF use
- First Sale of FelixTM in Research Application
- Verification and Validation Assessments Complete
Later from Memphasys
- Felix System commercialisation update
- Monash IVF clinical study enrols first patient using FELIX
- Suspension from Official Quotation
- $3.36 capital raising to accelerate FELIX commercialisation
- Rights Issue Closure and Shortfall Notification
Follow Memphasys into a list and get an email when it puts out news.
Follow Memphasys